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A B S T R A C T
Background: We have identiﬁed a strong association between daytime napping and increased mortali-
ty risk from respiratory diseases, but little is known about the relationship between daytime napping
and respiratory morbidity.
Methods: Data were drawn from the European Prospective Investigation into Cancer and Nutrition-
Norfolk cohort. Participants reported napping habits during 1998–2000 andwere followed up for respiratory
disease hospital admissions until March 2009. Cox proportional hazards regression was used to examine
the association between daytime napping and respiratory disease incidence risk.
Results: The study sample included 10,978 men and women with a mean age of 61.9 years, and a total
of 946 incident respiratory disease cases were recorded. After adjustment for age, sex, social class, ed-
ucation, marital status, employment status, nightshift work, body mass index, physical activity, smoking,
alcohol intake, self-reported general health, hypnotic drug use, habitual sleep duration, and preexisting
health conditions, daytime napping was associated with an increase in the overall respiratory disease
incidence risk (hazard ratio (HR) = 1.32, 95% conﬁdence interval (CI) 1.15, 1.52 for napping <1 h; HR = 1.54,
95% CI 1.14, 2.09 for napping ≥1 h). This association was more pronounced for lower respiratory dis-
eases, especially for the risk of chronic lower respiratory diseases (HR = 1.52, 95% CI: 1.18, 1.96 for napping
<1 h; HR = 1.72, 95% CI: 1.01, 2.92 for napping ≥1 h, overall p = 0.003).
Conclusions: Excessive daytime napping might be a useful marker of future respiratory disease inci-
dence risk. Further studies are required to conﬁrm these ﬁndings and help understand potential mechanisms.
© 2016 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Despite growing interest in the inﬂuence of comorbid sleep dis-
orders on the progression of respiratory diseases [1], the association
between habitual sleep and the onset of respiratory diseases has
rarely been studied. Our group has identiﬁed an intriguing associ-
ation between daytime napping and increased mortality risk,
particularly from respiratory diseases [2]. While the underlying
mechanism remains unclear, the examination of the association
between napping and respiratory disease would generate increased
interest in the study of napping habits [3,4]. Daytime napping has
been suggested as a marker of obstructive sleep apnea (OSA) [5],
but it could also be a more global indicator of respiratory disease.
Understanding the link between napping and respiratory morbid-
ity might help with the early detection and control of respiratory
disease. We therefore examined the association between daytime
napping and the incidence risk of non-fatal respiratory diseases in
the European Prospective Investigation into Cancer and Nutrition
(EPIC)-Norfolk prospective cohort study [6].
2. Materials and methods
A total of 25,639 participants recruited through general prac-
tice registers attended the baseline health check in1993–1997 and
were followed up for health outcomes. As part of the follow-up, par-
ticipants were sent questionnaires for completion and returned by
post. The Norwich District Ethics Committee approved the study and
all participants gave signed informed consent. During 1998–2000,
16,374 participants completed the following question “Do you
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normally take a nap during the day?” and were asked to indicate
the duration of their nap as either <1 h or ≥1 h if they reported
napping.We obtained data on all hospital admissions through linkage
with the National Health Services health district database. The UK
Oﬃce of National Statistics ﬂagged all participants according to the
International Classiﬁcation of Disease 10th Revision (ICD-10). All
respiratory diseases were deﬁned as J00-J99 and were subdivided
into chronic lower respiratory diseases (J40-J47), lower respiratory
infections (J10-J22, J85), and upper respiratory diseases (J00-J06,
J30-J39). The current analysis presents hospital admissions for re-
spiratory disease followed up from January 2000 until March 2009.
The association between daytime napping (summarized as no
napping, napping <1 h/day, and napping ≥1 h/day) and respiratory
disease incidenceriskwasexaminedusingCoxregression.All covariates
were chosen a priori and have been described in detail previously
[2]. Analysis was conﬁned to participants without self-reported re-
spiratory diseases at the baseline and those with complete data on
all covariates. The fully adjusted model included sociodemographic
factors, body mass index (BMI), health-related behaviors, self-
reported general health, habitual sleep duration, and comorbidities.
The comorbidities included stroke, myocardial infarction, diabetes,
cancer, and a proxy measure of OSA, with participants who were in
the highest BMI quartile and who reported taking antihypertension
drugs being deﬁned as likely to have underlying OSA. Analyses were
implemented inStata, version12.0 (StataCorpLP,CollegeStation,Texas).
3. Results
After excluding participants with a history of asthma, bronchitis,
and emphysema and those reporting chronic obstructive pulmonary
disease (COPD) drug use at the baseline (n = 2773), the study sample
consisted of 10,978 participants (4903men and 6075 women, mean
age 61.9 ± 9.0 years) with complete data on all covariates. At the base-
line, 1700 (35%) men and 1400 (23%) women reported taking naps.
Fig. 1 shows the percentage of certain baseline characteristics by
napping. Those who reported napping were older, more likely to
be men, smokers, and have comorbidities. Supplemental Table S1
summarizes the detailed relationship between covariates and
napping habits. Those who reported long napping were more likely
to have lower education, higher BMI, poorer general health, longer
sleep duration, and be less active.
A total of 946 incident respiratory disease hospital admissions
(including 286 from chronic lower respiratory diseases, 452
from lower respiratory infection, and 146 from upper respiratory
diseases) were recorded over 9.25 years of follow-up. After adjust-
ment for age and sex, napping was associated with a 40% (for
napping <1 h/day) to 94% (for napping ≥1 h/day) increase in the
overall respiratory disease incidence risk (Table 1). The associa-
tion remained even after adjustment for all covariates (hazard ratio
(HR) = 1.32, 95% conﬁdence interval (CI) 1.15, 1.52 for napping <1 h;
HR = 1.54, 95% CI 1.14, 2.09 for napping ≥1 h). This association was
more pronounced for lower respiratory diseases, especially chronic
lower respiratory diseases (for napping ≥1 h, HR = 1.72, 95% CI: 1.01,
2.92; overall p = 0.003).
When we examined two major chronic lower respiratory dis-
eases separately, daytime napping (of any length) was associated
with the risk of both COPD (HR = 1.64, 95% CI 1.17, 2.30) and asthma
(HR = 1.50, 95% CI 1.07, 2.09) after multivariable adjustment.
4. Discussion
In this large prospective study of middle- to older-aged British
adults, napping was associated with a 32–54% increase in the in-
cidence risk of respiratory disease hospital admissions, independent
of smoking, comorbidities, and habitual sleep duration. The risk of
chronic lower respiratory disease was more than 70% higher among
those who napped ≥1 h per day than among those who did not nap.
To our knowledge, this is the ﬁrst study to report an associa-
tion between daytime napping and increased incident respiratory
diseases. Detailed hospital records on incident respiratory diseases
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Fig. 1. Percentage of baseline characteristics by napping habits in 10,978 men and women, EPIC-Norfolk, United Kingdom, 1998–2000.
*Stroke, myocardial infarction, cancer, and underlying sleep apnea.
The association between napping and each characteristic was tested by Pearson’s χ2 square test, all P < 0.001.
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were obtained over a follow-up period of more than 9 years, and
subtypes of respiratory diseases were examined to help under-
stand the mechanisms. The effect sizes were reasonably large, even
after controlling for the effects of a range of covariates, including
smoking and comorbidities. These new results add to our earlier
ﬁndings on the association between napping and increased respi-
ratory mortality risk [2] and lend further support to the potentially
important role of identifying excessive daytime napping for the early
detection of respiratory diseases in primary care settings.
Previously discussed study limitations [2] include potential re-
portingbias and the crude categorizationof nappingdurations,which
might not capture the effects of power naps and could have diluted
the overall associations. However, we observed a consistently in-
creased overall respiratory risk associated with increasing daytime
napping durations. Another limitation concerns the generalizability
of these ﬁndings, following inclusion of participants with complete
data on all covariates. Included participants were younger and had
a more favorable socioeconomic and health proﬁle than the rest of
the population. While this might have inﬂuenced the external va-
lidity of the study, within-population associations were unlikely to
have been biased as the incidence of respiratory diseaseswas similar
between those includedandexcluded fromtheanalysis. Finally, sleep-
related breathing problemswere not recorded in this study.Wehave
used a proxymeasure, combining two strong correlates of OSA [7–9],
to account for the effect, but the possibility of residual confounding
cannot be ruled out. However, OSA is underdiagnosed and poorly
characterized in the general population [10], whereas excessive
daytime napping is a noticeable behavior. Therefore, even if some
of the observed associationsmight have been attributed to OSA, ex-
cessive daytime napping is potentially useful as a clinical marker in
predicting future respiratory hospital admission risk.
Although we are aware of no other studies with which our ﬁnd-
ings could be directly compared, the present study complements
our previous ﬁnding [2] that highlighted an increased respiratory
mortality risk associated with napping. The Nurses’ Health Study
II suggested an increased pneumonia risk among those with extreme
sleep duration [11], possibly through the inﬂuence on immune func-
tion.We also found the association between napping and respiratory
disease more pronounced for lower respiratory conditions, al-
though the effect was stronger for chronic lower respiratory diseases
rather than respiratory infections.While it is unclear whether a phys-
iological link exists between sleep and the lower respiratory system,
the identiﬁcation of potential mechanisms is crucial. Notably, our
ﬁndings on napping durations and subtypes of respiratory dis-
eases should be interpreted cautiously due to the relatively small
number of cases in certain subcategories, and these intriguing results
need to be conﬁrmed by larger prospective studies in the future.
The exact biological effects of daytime napping have not been
well studied. Daytime napping has been associated with elevated
levels of inﬂammatory biomarkers [12]; airway inﬂammation is the
major mechanism for chronic lower respiratory diseases [13,14].
Notably, the purpose of napping was not recorded in the present
study, and those who took naps could be suffering from daytime
sleepiness due to disturbed nighttime sleep, which could also trigger
the inﬂammatory process [15,16]. Given the high prevalence of ex-
cessive daytime sleepiness reported by COPD and asthma patients
[17], it is questionable whether daytime napping could be a symptom
of respiratory disorders. However, we excluded participants with
a self-reported history of respiratory problems, making it plausi-
ble that napping precedes the onset of respiratory diseases. Although
the inﬂuence of other sleep disorders or unmeasured comorbidities
cannot be excluded, daytime napping as a noticeable behavior may
be useful as a sensitive marker of future respiratory disease. Further
work is required to conﬁrmwhether there exists a biological pathway
through which napping could lead to incident respiratory diseases.
In conclusion, napping was associated with increased risk of
incident respiratory disease, especially the risk of incident chronic
lower respiratory diseases. Excessive daytime napping might be a
useful marker of increased respiratory risk, and identiﬁcation of this
behavior is potentially important for the early detection of respi-
ratory diseases in clinical practice.
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